Benzinga | Jan 27, 2021 11:26AM EST

Alliance Global Partners Downgrades T2 Biosystems to Neutral, Lowers Price Target to $2.4

Alliance Global Partners analyst Ben Haynor downgrades T2 Biosystems (NASDAQ:TTOO) from Buy to Neutral and lowers the price target from $2.6 to $2.4.